Search
Gilead Sciences Inc
GILDAdd to Watchlist
150.560USD
+0.450+0.30%
Close 09-21 16:00（ET）
186.84BMarket Cap
20.31P/E TTM
Gilead Sciences Inc (GILD) Stock Price Target & Forecast
Analyst Rating
Based on 31 analysts giving stock ratings to Gilead Sciences Inc in the past month.
Buy
7 Strong Buy
18 Buy
6 Hold
0 Sell
0 Strong Sell
Target Price
158.534USD+5.61%
GILD Analyst Recommendation Trends
In the current month, GILD has received 18 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. GILD average Analyst price target in the last month is 158.534.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
7
8
9
9
8
8
8
8
18
18
17
17
17
17
16
16
6
5
7
7
7
6
7
7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
31
31
33
33
32
31
31
31
GILD Analyst Rating for Peer Comparison
Updated: Sep 21, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Amgen Inc
AMGN
4
12
18
2
1
37
Biogen Inc
BIIB
7
17
12
1
0
37
Eli Lilly and Co
LLY
10
17
6
1
0
34
AbbVie Inc
ABBV
8
19
6
0
0
33
Regeneron Pharmaceuticals Inc
REGN
6
15
11
0
0
32
Merck & Co Inc
MRK
8
14
10
0
0
32
Pfizer Inc
PFE
5
6
19
1
1
32
Vertex Pharmaceuticals Inc
VRTX
9
16
5
0
1
31
Bristol-Myers Squibb Co
BMY
5
6
18
2
0
31
Alnylam Pharmaceuticals Inc
ALNY
5
18
7
0
0
30
Financial Forecasting
Based on analysts' estimates, GILD EPS is projected to reach 2.138 in FY2026Q3, following reported EPS of -8.444 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
1.81
1.91
-7.24
2.14
2.18
Actual
6.84
1.63
-8.44
--
--
Surprise
+277.87%
-14.99%
-16.71%
--
--
FAQs
What is Gilead Sciences Inc's expected revenue for the next quarter?
Gilead Sciences Inc's expected revenue is 7.76B.
What is Gilead Sciences Inc's price target?
Analysts forecast that Gilead Sciences Inc's price target is USD 158.53, with the highest forecast at USD 180.00 and the lowest forecast at USD 123.00.
How have Gilead Sciences IncGILD's recent earnings per share performed?
The market expectation was USD -8.44, while Gilead Sciences IncGILD's earnings per share (EPS) for the previous quarter was USD 1.63. EPS for the next quarter is expected at USD 2.14.
What is the analyst rating for Gilead Sciences Inc?
Based on the ratings of Gilead Sciences Inc's stock from 31 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.